1995
Discovery of TKTL1
Dr. Johannes Coy Discovers new universal biomarker at the German Institute for Cancer Research2007
Foundation of Zyagnum AG
Zyagnum is founded to develop a technology platform and diagnostic test for cancer2010
First in-house test
The first cancer-in-house test based on TKTL1 is launched in Germany - testing accuracy is not reliable and high enough for a commercial screening test2017
Development completed
Zyagnum finishes development of the unique EDIM technology and achieves registration of the PanTum Detect cancer screening test2018
PanTum Detect
Global market launch & development of additional tests.